| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/01/2001 | WO2001007460A1 FucR |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007458A1 lacR |
| 02/01/2001 | WO2001007442A1 Beta-amyloid peptide inhibitors |
| 02/01/2001 | WO2001007084A1 Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery |
| 02/01/2001 | WO2001007081A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007059A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2001 | WO2001006989A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006910A2 VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN β2- ADRENERGIC RECEPTOR |
| 02/01/2001 | WO2001006849A1 Transgenic animal model for kaposi's sarcoma |
| 02/01/2001 | WO2001006848A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000063248A3 Highly purified gonadotropin compositions and process for preparing them |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000058464A3 Rab genes and their uses |
| 02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
| 02/01/2001 | WO2000056357A3 Staphylococcus antigen and vaccine |
| 02/01/2001 | WO2000053756A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000052047A3 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000037493A3 Type iii secretion system antigens from bordetella pertussis |
| 02/01/2001 | WO2000024772A3 Scorpion toxins |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | WO2000011035A9 Hiv suppressor factor derived from scrub typhus |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
| 02/01/2001 | DE19935663A1 Transfecting human chromosome 7 into Escherichia coli, useful for generating products for treatment of cystic fibrosis |
| 02/01/2001 | DE19935508A1 Producing a glycoprotein product that stimulates tumor necrosis factor alpha production, useful for treating cancer and viral infections, comprises culturing Rhodococcus fascians |
| 02/01/2001 | DE19935105A1 DNA-Sequenzen, die Exportsysteme kodieren DNA sequences encoding export systems |
| 02/01/2001 | DE19935088A1 DNA-Sequenzen, die sich zum spezifischen Nachweis von Pseudomonas putida KT2440 eignen DNA sequences that are suitable for the specific detection of Pseudomonas putida KT2440 |
| 02/01/2001 | DE19934894A1 Collagen particles for use as drug carriers, e.g. for administration of proteins or peptides by injection, prepared from emulsion containing collagen solution or dispersion without using crosslinking agents |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2693274A1 Peptide acceptor ligation methods |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380330A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380178A1 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 02/01/2001 | CA2380037A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | CA2379863A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379777A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | CA2379400A1 Recombinant high molecular weight major outer membrane protein of moraxella |
| 02/01/2001 | CA2379251A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | CA2379241A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association |
| 02/01/2001 | CA2379237A1 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | CA2378953A1 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378779A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 02/01/2001 | CA2378403A1 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | CA2378107A1 <i>arabidopsis thaliana</i> cyclic nucleotide-gated ion channel/<i>dnd</i> genes; regulators of plant disease resistance and cell death |
| 02/01/2001 | CA2375650A1 Ehrlichia canis genes and vaccines |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 02/01/2001 | CA2343714A1 Homeobox gene encoding a protein involved in differentiation |
| 01/31/2001 | EP1072682A1 Protein and gene participating in the differentiation of immortalized cells |
| 01/31/2001 | EP1072681A2 Human-keratinocytes regulator protein pKe#165 |
| 01/31/2001 | EP1072680A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/31/2001 | EP1072611A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 01/31/2001 | EP1072610A1 Novel cytokine-like protein |
| 01/31/2001 | EP1072609A2 Cytoprotective agents comprising prosaposin-related peptides |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071953A1 Detection and diagnosis of conditions associated with lung injury |
| 01/31/2001 | EP1071952A1 I kappa b and enhanced green fluorescent fusion protein |
| 01/31/2001 | EP1071825A2 Method for typing of hla alleles |
| 01/31/2001 | EP1071823A2 Novel mutations in the (freac3 )gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/31/2001 | EP1071819A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine |
| 01/31/2001 | EP1071806A2 Materials and methods for gene therapy |
| 01/31/2001 | EP1071804A1 Use of triplex structure dna sequences for transferring nucleotide sequences |
| 01/31/2001 | EP1071803A1 Stress tolerant plants |
| 01/31/2001 | EP1071799A1 Seed specific polycomb group gene and methods of use for same |
| 01/31/2001 | EP1071798A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 01/31/2001 | EP1071797A2 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria |
| 01/31/2001 | EP1071795A1 Canine erythropoietin gene and recombinant protein |
| 01/31/2001 | EP1071794A1 A method for inhibiting tumor invasion or spreading in a subject |
| 01/31/2001 | EP1071784A1 Polypeptides from moraxella (branhamella) catarrhalis |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071782A2 Seed-coat promoters, genes and gene products |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071780A1 Soluble protein ztmpo-1 |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071778A2 Srebp-2-deficient cell lines |
| 01/31/2001 | EP1071777A2 Human nucleic acid sequences of normal uterus tissue |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071775A2 Human nucleic acid sequences of endometrium tumour tissue |
| 01/31/2001 | EP1071774A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071772A2 Fizz proteins |